share_log

AbbVie | 144/A: Others

SEC announcement ·  Mar 22 02:32
Summary by Futu AI
Abbvie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company on 03/20/2024, with an aggregate market value of approximately $3.72 million. The shares were acquired on 02/28/2024 as performance shares, a form of compensation from the issuer. This transaction follows a previous sale of 2,912 retail shares on 12/26/2023, which grossed $450,640.30.
Abbvie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company on 03/20/2024, with an aggregate market value of approximately $3.72 million. The shares were acquired on 02/28/2024 as performance shares, a form of compensation from the issuer. This transaction follows a previous sale of 2,912 retail shares on 12/26/2023, which grossed $450,640.30.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.